Medicine is undergoing some profound changes in the 21st century—shouldn’t clinical trials follow suit? This new EPAM blog post agrees heartily with this sentiment, and makes the case for using decentralized clinical trials, or DCTs. What are the benefits of DCTs? Well, they can increase collaboration, improve clinician adoption, and help with outreach to minority populations, to name just three. Trials without tribulations indeed.
filed in: Life sciences
